Physica System Trabecular Titanium Tibial Plate – 1st Surgery Performed by Dr. Ivan De Martino

Physica system Trabecular Titanium Tibial Plate first surgery was performed on  April 29th. Dr. Ivan De Martino performed his first surgery at Agostino Gemelli IRCCS University Hospital Foundation of Rome.

Dr. De Martino is a Hospital for Special Surgery (HSS) fellowship-trained orthopedic surgeon, specializing in complex joint replacement and revision in the Department of Orthopedics directed by prof. Giulio Maccauro. Prior to his current position, Dr. De Martino spent seven years working at HSS and is one of the surgeon designers of this implant.

Upon completing the procedure, Dr. De Martino stated, “The case went well and I’m very satisfied with the outcome. The preparation of the tibial component was quick and easy, and the feeling during impaction was good, the implant was well seated and the fixation rock-solid. The patient was a young male, and I am confident this implant will support his comeback to an active life.”

The Physica system TT Tibial Plate was designed by LimaCorporate in collaboration with the Department of Biomechanics at HSS led by its Director, Timothy Wright, PhD., and Director of Device Development, Joseph Lipman. Headquartered in New York City, HSS is the largest academic medical center specialized in musculoskeletal health and is ranked the #1 hospital in the world for Orthopedics by Newsweek.

“The engineers and surgeons at HSS were delighted to be part of this exciting development effort in close collaboration with our colleagues from LimaCorporate,” stated Dr. Wright.

Embracing the design expertise of HSS and more than 14 years of innovation in 3D printing and clinical history of Trabecular Titanium™ (TT), the Physica system TT Tibial Plate is a state-of-the-art implant that enables LimaCorporate to enter the growing cementless total knee market.

The Physica system TT Tibial Plate is designed to offer a more bone preserving implant with long-term biological fixation compared to standard cemented designs. This will deliver additional benefits to the younger more active patient.

“The use of Trabecular Titanium™ we believe will be a significant advance in cementless total knee design improving osseous integration into the implant and improving outcomes for our patients” stated Dr. Thomas Sculco, Surgeon-in-Chief Emeritus of HSS and one of the surgeon designers of the TT Tibial Plate.

Luigi Ferrari, LimaCorporate CEO, commented: “TT Tibial plate is an important addition to the Physica system and will enable LimaCorporate to approach a new segment of the total knee market. This latest product represents another important milestone for us. I’m excited about the positive impact it will have in helping surgeons to restore the eMotion of motion in their patients.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”